Wellington Management Group LLP boosted its holdings in Amgen Inc. (NASDAQ:AMGN - Free Report) by 1,102.7% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,742,271 shares of the medical research company

Kingsview Wealth Management LLC acquired a new stake in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 18,729 shares of the medical research company

Kimelman & Baird LLC acquired a new stake in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 14,240 shares of the medical research company

Nissay Asset Management Corp Japan boosted its stake in Amgen Inc. (NASDAQ:AMGN - Free Report) by 6.5% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 159,700 shares of the medical research company

Glenview Trust Co bought a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor bought 8,321 shares of the medical research company

Strait & Sound Wealth Management LLC bought a new stake in Amgen Inc. (NASDAQ:AMGN - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 5,292 shares of the medical research company

RB Capital Management LLC purchased a new position in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 16,121 shares of the medical research compa

Ferguson Wellman Capital Management Inc. lessened its stake in Amgen Inc. (NASDAQ:AMGN - Free Report) by 22.6% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 247,072 shares of the medical research company

Field & Main Bank acquired a new stake in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 7,076 shares of the medical research company

Caisse de depot et placement du Quebec trimmed its position in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 15.2% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 47,809 shares of the

Beacon Pointe Advisors LLC acquired a new stake in Amgen Inc. (NASDAQ:AMGN - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 108,053 shares of the medical research company

Shares of Amgen Inc. (NASDAQ:AMGN - Get Free Report) have been assigned an average recommendation of "Hold" from the thirty-one brokerages that are currently covering the company, MarketBeat reports. Three equities research analysts have rated the stock with a sell rating, fourteen have assigned a

Amgen stock is supported by a Q2 2026 beat, a raised FY 2026 outlook and a recent analyst call. Shar

Amgen stock is trading close to its 52-week high after Q2 2026 revenue of $10.05 billion and EPS of

North Star Asset Management Inc. purchased a new position in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 10,471 shares of the medical

United Capital Financial Advisors LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 90,846 shares of the medical research company

Valueworks LLC acquired a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 10,978 shares of the medical research company

Pacific Heights Asset Management LLC purchased a new position in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 90,000 shares of the medical research company

Jefferies Financial Group Inc. acquired a new position in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 239,779 shares of the medical research compan